2016
DOI: 10.1183/13993003.01444-2016
|View full text |Cite
|
Sign up to set email alerts
|

Gastro-oesophageal reflux and idiopathic pulmonary fibrosis: in search of evidence

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
2
1

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 21 publications
0
2
0
Order By: Relevance
“…Gastroesophageal re ux disease (GERD) is a prevalent condition that affects approximately 20% of adults in developed countries, and can result in various uncomfortable symptoms and/or complications within and outside the esophagus [6]. Numerous studies have reported that GERD is a common complication of IPF [7][8][9][10], with multiple cohort studies and meta-analyses con rming the close relationship between both conditions [11][12][13][14]. Although the discussion regarding the potential relationship between GERD and IPF can be traced back to the 1970s [15], the connection between the two remains unclear.…”
Section: Introductionmentioning
confidence: 99%
“…Gastroesophageal re ux disease (GERD) is a prevalent condition that affects approximately 20% of adults in developed countries, and can result in various uncomfortable symptoms and/or complications within and outside the esophagus [6]. Numerous studies have reported that GERD is a common complication of IPF [7][8][9][10], with multiple cohort studies and meta-analyses con rming the close relationship between both conditions [11][12][13][14]. Although the discussion regarding the potential relationship between GERD and IPF can be traced back to the 1970s [15], the connection between the two remains unclear.…”
Section: Introductionmentioning
confidence: 99%
“…Gastroesophageal reflux is particularly frequent in IPF and may contribute to repeated alveolar epithelium injury and lung fibrosis progression [3]. Anti-reflux therapy, including proton pump inhibitors and anti-reflux surgery, have been suggested to influence the progression of lung function decline and exacerbation rate in IPF patients [4,5] although this remains a matter of debate in the absence of any direct evidence from randomized trials [6,7]. Interestingly, recent observations indicate that proton pump inhibitors may have antifibrotic activities by directly suppressing proinflammatory cytokines, profibrotic proteins, and proliferation of lung fibroblasts [4].…”
Section: Introductionmentioning
confidence: 99%